Elevation Oncology to Participate in Upcoming Investor Conferences
Provided By PR Newswire
Last update: Feb 28, 2024
BOSTON, Feb. 28, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced that members of management will participate in upcoming investor conferences in March:
Read more at prnewswire.com
